Retirement Group’s Protara Therapeutics TARA Stock Holding History

Retirement Group’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-500	Closed	-$5K	–	704
2021 Q2	$5K	Buy	+500	New	+$5.66K	﹤0.01%	498

Other funds holding TARA

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Retirement Group's TARA Position: Q3 2021 in Review

Retirement Group sold out of Protara Therapeutics (TARA) in Q3 2021, closing a stake of 500 shares — an estimated $5K sold.

Retirement Group first reported a position in TARA in Q2 2021 and held it in 1 quarter. The position peaked at $5K in Q2 2021. 36 funds tracked by Wall St. Rank hold TARA as of Q3 2021.

Retirement Group reported no remaining Protara Therapeutics position as of Q3 2021 after selling out during the quarter.
Retirement Group sold 500 Protara Therapeutics shares in Q3 2021, an estimated $5K.
Retirement Group first reported a position in Protara Therapeutics in Q2 2021 and held it in 1 quarter.
Retirement Group's Protara Therapeutics position peaked at $5K in Q2 2021.
36 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2021.

Based on Retirement Group's 13F filing for Q3 2021, filed 16 Nov 2021.